App-Quantinova.ai

Identification of PD1 and TIM3 As Checkpoints That Limit Chimeric Antigen Receptor T Cell Efficacy in Leukemia

Saad S Kenderian - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

HLA-DPB1 Mismatch Induces Low Hematological Relapse and Beneficial Survival in Single Unit Cord Blood Transplantation

Toshio Yabe - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

N/A

Minimal Residual Disease Monitoring By Two Sensitive Techniques May Contribute to Improved Outcome of Allogeneic Transplantation for Ph(-) Acute Lymphoblastic Leukemia

Damianos Sotiropoulos - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Allopurinol

Total Marrow Irradiation (TMI) Based T- Replete Myeloablative Haploidentical Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Second Complete Remission: A Single Center Experience of Two Cases

Joydeep Chakrabartty - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

Cyclophosphamide

Tailored Post-Transplant Maintenance with Tyrosine Kinase Inhibitors for High-Risk Philadelphia Chromosome-Positive Leukemia

Zachariah DeFilipp - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

L-Tyrosine

Busulfan-Based Allogeneic Hematopoietic Cell Transplantation with Various Donor Type Including Haploidentical Familial Mismatched Donor as Post-Remission Therapy in Adult Acute Lymphoblastic Leukemia

Dae-Young Kim - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

Cyclophosphamide

Does Partial Donor Chimerism (PDC) Increase the Risk of Relapse in Pediatric Patients with Leukemia Undergoing Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT)

Sana Khan - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

fludarabine tablet

Reduced Intensity Fludarabine and Intravenous Busulfan (FB2) for Allogeneic Peripheral Blood Stem Cell Transplantation

Parikshit Padhi - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

Mycophenolate mofetil

The Use of Hyperbaric Oxygen Therapy for Refractory Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Leyre Bento - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

HWA-486

Concurrent Use of Blinatumomab and Donor Lymphocyte Infusion (DLI) for Treatment of Relapsed Precursor B Cell Acute Lymphoblastic Leukemia (pre B ALL) after Allogeneic Hematopoietic Cell Transplant (HCT)

Masumi Ueda - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

Blinatumomab

Outcome of Unmanipulated HLA-Mismatched/Haplo-Matched Hematopoietic Cell Transplantation from Related Donors in Patients with Fanconi Anemia Using Low Dose Post HCT Cyclophosphamide for Gvhd Prophylaxis

Mouhab Ayas - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

Cyclophosphamide

The Contribution of Posttransplant RBC Transfusions and Missing Dose of Methotrexate Prophylaxis to the Development of Acute Graft Versus Host Disease in Children

Ulker Kocak - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Cyclosporine eent

Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

Marco Mielcarek - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

Cyclophosphamide

Bone Marrow Cellular Components and Their Relationship on Survival and Relapse in Pediatric Acute Lymphocytic Leukemia Patients

Hawazen Saleh Alsaedi - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

INTERACTION BETWEEN AN IN VITRO SELECTED ROTAVIRUS AND SEVERAL HEAT SHOCK PROTEINS (HSPS) DURING THE INFECTION PROCESS IN CELL LINES U-937 AND REH

J. C. Hernandez - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

cyclodextrin

A NEW PARADIGM FOR CANCER THERAPY: A TARGETED SYSTEMIC PREVENTIVE/THERAPEUTIC APPROACH

S. Crawford - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

INHIBITION OF CASEIN KINASE II (CK2) ENHANCES IKAROS TUMOR SUPPRESSOR ACTIVITY AND SHOWS THERAPEUTIC EFFICACY IN A PRECLINICAL LEUKEMIA MODEL

S. Dovat - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Casein

Growth Impairment in Children with Acute Leukemia

In Ah Jung - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

hGH

Clonal Progression Including Evolution Of An iAMP21 Chromosome In Xenograft Models Of BCP-ALL

Paul B Sinclair - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Identification and Characterization By ChIP-Seq Of Genomic Sites Bound By E2A-PBX1 In Acute Lymphoblastic Leukemia Demonstrates Associations With p300 Recruitment, Transcriptionally Active Chromatin and Abundant Transcription

Kyster Nanan - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Filters

2187 Abstracts